|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benedet JL, Odicino F, Maisonneuve P,
Beller U, Creasman WT, Heintz AP, Ngan HY, Sideri M and Pecorelli
S: Carcinoma of the cervix uteri. J Epidemiol Biostat. 6:7–43.
2001.PubMed/NCBI
|
|
3
|
Burghardt E, Pickel H, Haas J and Lahousen
M: Prognostic factors and operative treatment of stages IB to IIB
cervical cancer. Am J Obstet Gynecol. 156:988–996. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Van Bommel PF, Van Lindert AC, Kock HC,
Leers WH and Neijt JP: A review of prognostic factors in
early-stage carcinoma of the cervix (FIGO I B and II A) and
implications for treatment strategy. Eur J Obstet Gynecol Reprod
Biol. 26:69–84. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Acmaz G, Aksoy H, Unal D, Ozyurt S,
Cingillioglu B, Aksoy U and Muderris I: Are neutrophil/lymphocyte
and platelet/lymphocyte ratios associated with endometrial
precancerous and cancerous lesions in patients with abnormal
uterine bleeding? Asian Pac J Cancer Prev. 15:1689–1692. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Babu SN, Chetal G and Kumar S: Macrophage
migration inhibitory factor: A potential marker for cancer
diagnosis and therapy. Asian Pac J Cancer Prev. 13:1737–1744. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Absenger G, Szkandera J, Stotz M,
Postlmayr U, Pichler M, Ress AL, Schaberl-Moser R, Loibner H,
Samonigg H and Gerger A: Preoperative neutrophil-to-lymphocyte
ratio predicts clinical outcome in patients with stage II and III
colon cancer. Anticancer Res. 33:4591–4594. 2013.PubMed/NCBI
|
|
8
|
Migita K, Takayama T, Saeki K, Matsumoto
S, Wakatsuki K, Enomoto K, Tanaka T, Ito M, Kurumatani N and
Nakajima Y: The prognostic nutritional index predicts long-term
outcomes of gastric cancer patients independent of tumor stage. Ann
Surg Oncol. 20:2647–2654. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanda M, Fujii T, Kodera Y, Nagai S,
Takeda S and Nakao A: Nutritional predictors of postoperative
outcome in pancreatic cancer. Br J Surg. 98:268–274. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang
J, Wang T, Zhu W and Liu P: Prognostic value of PLR in various
cancers: A meta-analysis. PLoS One. 9:e1011192014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fathalla MF: Factors in the causation and
incidence of ovarian cancer. Obstet Gynecol Surv. 27:751–768. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kobayashi T, Teruya M, Kishiki T, Endo D,
Takenaka Y, Tanaka H, Miki K, Kobayashi K and Morita K:
Inflammation-based prognostic score, prior to neoadjuvant
chemoradiotherapy, predicts postoperative outcome in patients with
esophageal squamous cell carcinoma. Surgery. 144:729–735. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Haruma T, Nakamura K, Nishida T, Ogawa C,
Kusumoto T, Seki N and Hiramatsu Y: Pre-treatment neutrophil to
lymphocyte ratio is a predictor of prognosis in endometrial cancer.
Anticancer Res. 35:337–343. 2015.PubMed/NCBI
|
|
14
|
Cummings M, Merone L, Keeble C, Burland L,
Grzelinski M, Sutton K, Begum N, Thacoor A, Green B, Sarveswaran J,
et al: Preoperative neutrophil: Lymphocyte and platelet: Lymphocyte
ratios predict endometrial cancer survival. Br J Cancer.
113:311–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mizunuma M, Yokoyama Y, Futagami M, Aoki
M, Takai Y and Mizunuma H: The pretreatment
neutrophil-to-lymphocyte ratio predicts therapeutic response to
radiation therapy and concurrent chemoradiation therapy in uterine
cervical cancer. Int J Clin Oncol. 20:989–996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kose M, Celik F, Kose SK, Arioz DT and
Yilmazer M: Could the platelet-to-lymphocyte ratio be a novel
marker for predicting invasiveness of cervical pathologies? Asian
Pac J Cancer Prev. 16:923–926. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim
YT and Lee K: Pre-treatment neutrophil to lymphocyte ratio is
elevated in epithelial ovarian cancer and predicts survival after
treatment. Cancer Immunol Immunother. 58:15–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Asher V, Lee J, Innamaa A and Bali A:
Preoperative platelet lymphocyte ratio as an independent prognostic
marker in ovarian cancer. Clin Transl Oncol. 13:499–503. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim SH, Kim SC, Choi BI and Han MC:
Uterine cervical carcinoma: Evaluation of pelvic lymph node
metastasis with MR imaging. Radiology. 190:807–811. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nozoe T, Ninomiya M, Maeda T, Matsukuma A,
Nakashima H and Ezaki T: Prognostic nutritional index: A tool to
predict the biological aggressiveness of gastric carcinoma. Surg
Today. 40:440–443. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
U.S. Department of Health and Human
Services; National Institutes of Health. National Cancer Institute,
. Common Terminology Criteria for Adverse Events (CTCAE) v4.0.
2010.
|
|
22
|
Kodama J, Takemoto M, Seki N, Nakamura K,
Hongo A, Moriya S, Kanazawa S and Hiramatsu Y: Phase I study of
chemoradiation with nedaplatin and ifosfamide in patients with
advanced squamous cell carcinoma of uterine cervix. Int J Gynecol
Cancer. 18:1300–1304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kodama J, Takemoto M, Seki N, Nakamura K,
Hongo A, Kanazawa S and Hiramatsu Y: Phase I study of weekly
nedaplatin and concurrent pelvic radiotherapy as adjuvant therapy
after radical surgery for cervical cancer. Int J Gynecol Cancer.
18:1037–1041. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Münstedt K, Johnson P, Bohlmann MK,
Zygmunt M, von Georgi R and Vahrson H: Adjuvant radiotherapy in
carcinomas of the uterine cervix: The prognostic value of
hemoglobin levels. Int J Gynecol Cancer. 15:285–291. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schreiber RD, Old LJ and Smyth MJ: Cancer
immunoediting: Integrating immunity's roles in cancer suppression
and promotion. Science. 331:1565–1570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jackson JR, Seed MP, Kircher CH,
Willoughby DA and Winkler JD: The codependence of angiogenesis and
chronic inflammation. FASEB J. 11:457–465. 1997.PubMed/NCBI
|
|
28
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Assoian RK and Sporn MB: Type beta
transforming growth factor in human platelets: Release during
platelet degranulation and action on vascular smooth muscle cells.
J Cell Biol. 102:1217–1223. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dubernard V, Arbeille BB, Lemesle MB and
Legrand C: Evidence for an alpha-granular pool of cytoskeletal
protein alpha-actinin in human platelets that redistributes with
the adhesive glycoprotein thrombospondin-1 during the exocytotic
process. Arterioscler Tromb Vasc Biol. 17:2293–2305. 1997.
View Article : Google Scholar
|
|
31
|
Kaplan KL, Broekman MJ, Chernoff A,
Lesznik GR and Drillings M: Platelet alpha-granule proteins:
Studies on release and subcellular localization. Blood. 53:604–618.
1979.PubMed/NCBI
|
|
32
|
Gupta D and Lis CG: Pretreatment serum
albumin as a predictor of cancer survival: A systematic review of
the epidemiological literature. Nutr J. 9:692010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin X, Li W, Lai J, Okazaki M, Sugimoto S,
Yamamoto S, Wang X, Gelman AE, Kreisel D and Krupnick AS: Five-year
update on the mouse model of orthotopic lug transplantation:
Scientific uses, tricks of the trade, and tips for success. J
Thorac Dis. 4:247–258. 2012.PubMed/NCBI
|
|
34
|
Yao ZH, Tian GY, Wan YY, Kang YM, Guo HS,
Liu QH and Lin DJ: Prognostic nutritional index predicts outcomes
of malignant pleural mesothelioma. J Cancer Res Clin Oncol.
139:2117–2123. 2013. View Article : Google Scholar : PubMed/NCBI
|
